Related Experiment Videos
Sequence of the porcine interferon-gamma (IFN-gamma) gene
R Dijkmans1, K Vandenbroeck, E Beuken
1Rega Institute for Medical Research, Katholieke Universiteit Leuven, Belgium.
Nucleic Acids Research
|July 25, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study.
The pharmacogenomics journal·2016
[Interhospital transfer of ECMO-assisted patients in Martinique].
Annales francaises d'anesthesie et de reanimation·2013
[Piet de Somer, the University of Leuven and the Belgium poliovaccine in 1956-57].
Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie·2012
Analysis of the IL28RA locus as genetic risk factor for multiple sclerosis.
Journal of neuroimmunology·2012
Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England)·2011
ANKRD55 and DHCR7 are novel multiple sclerosis risk loci.
Genes and immunity·2011
Loss of SUMOylation drives aberrant PRC1 clustering and 3D genome rewiring independent of H3K27me3.
Nucleic acids research·2026
Structural insights into RNA phosphorylation by the RNase PNK module of the human rixosome complex.
Nucleic acids research·2026
An expanded realm of anti-CRISPR-associated proteins and regulatory mechanisms.
Nucleic acids research·2026
Ribosome dynamics at the conserved PGP motif governs 2A peptide-bond-skipping efficiency.
Nucleic acids research·2026
An outbreak of H7N7 high pathogenicity avian influenza in Victoria, Australia, in 2020.
Australian veterinary journal·2026
Herbal medicines against avian infectious bronchitis virus: shared host-directed and multi-stage antiviral pathways.
Frontiers in veterinary science·2026
Natural products against Babesiosis: active compounds, molecular mechanisms, application limitations and translational development.
Frontiers in cellular and infection microbiology·2026